Australia's largest stock trading and investment forum Australia's #1 stock forum

CGB

Click for more information

0.00%

2.1¢ cann global limited

Ann: A World First for MCL in Autoimmune Disease Reasearch, page-220

First 220 Last

Share
Profile

Follow
sh9dow

33 Posts.

6

03/03/18

16:31

Post #: 31503373
Share

Originally posted by Benrich2016 ↑

Directly from their Website -

Cann received the first licence issued by the Australian Government’s Office of Drug Control in February 2017, a research licence that will allow it to progress the development of medicinal cannabis. It has established relationships with organisations in both Australia and overseas that can supply elite genetics and collaborate on breeding programs.

In addition to the cannabis research licence the company, on 8 March 2017 Cann was issued Australia’s first Medicinal Cannabis Cultivation Licence. The new licence allows Cann Group to produce Australian grown material that can be prescribed for patient use.

So already they have Licences that QBL so desperately requires..

They also have an import /export licence granted by the ODC

So there's three things QBL is trying to achieve but hasn't yet..

They harvested crops already in Aug 2017 and are working with the CSIRO for clinical trials

Cann Group is producing medicinal cannabis for subsequent manufacturing into a final product that can be accessed by patients via clinical trials, or through the TGA’s Authorised Prescriber or Special Access Scheme.

These guys are purely a MM company and they have already got the licences they need.... With QBL still waiting for these and the time frames for clinical trials they'll have to go through I don't see Canntabs pills on the Market anytime soon..

You could argue that QBL has hemp but Cann group has plenty in the pipeline... While QBL chases these licences CAN is actually going through trials.. As far as MM is concerned these guys are well advanced in the MM arena!! For any drug to come on the market it takes time.. These guys will be a market leader in medical grade cannabis before most other MM companies.

My original buying into QBL was off the same view as yours.. Hemp and the ability to generate revenue.. When EXL listed and I learned more about other companies like Australian primary hemp and by observing what happened when hemp food laws changed I realised that QBL is actually not as advanced as I thought.. EXL's Hemp Foods Australia was in shops with the sticker not for human consumption well before the Laws changed..

QBL would do themselves a huge favour IMO by not trying to drop a huge headline World First and actually just report on what they are doing...by not saying those things they'd sound so much more ligitimat and not so desperate!

I also feel that the company (QBL) should focus on hemp way more than MM because I feel it is their best chance to earn decent profits in the short term... Bauxite and MM products are a long way off.

Expand

I do agreed with some of the that u have pointed out but what i want to know is the following
- what is CAN current medical product?
- when did they have clinical trial on the product?
- when CAN phase 3 developement is complete for planting hence havesting?
So i think CAN sp and other similar similar company like CAN will slide while QBL sp has reach it bottom.
Where do you think QBL sp will be once they obtain MM and import/export licences?

QBL Price at posting: 4.9¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

ITM

iTech lifts MRE at Eyre Peninsula Graphite Project by 300%

Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25

LIN

Lindian shares jump on news of low-cost feasibility results for Kangankunde REE project

ASX Market Update: ASX200 in the red but real estate faring better | 1 June 2024

There are more pages in this discussion • 59 more messages in this thread...

First 220 Last

Add CGB (ASX) to my watchlist

SPONSORED BY